@Dmarti_aguado Profile picture

David Marti Aguado

@Dmarti_aguado

Hepatology Department. Clinic University Hospital of Valencia, Spain. INCLIVA Biomedical Research Institute. Virtual Liver Biopsy Research Group.

Similar User
Grupo Joven AEEH photo

@GrupoJovenAEEH

Mapi Ballester photo

@mapibafe

Virginia photo

@VirginiaHdezGea

Luis Téllez photo

@luistevilla

JC Garcia Pagan photo

@jcgarciapagan

Juan Turnes photo

@jturnesv

María Del Barrio Azaceta photo

@DelAzaceta

Joaquin Cabezas photo

@JCabezasGlez

Jordi Gracia-Sancho photo

@JSGracia

Sabela Lens García photo

@SaSi_Lens

Elba Llop Herrera photo

@ElbaLlop

Miguel R. Gandía photo

@RodriguezGandia

Maria Carlota Londoño photo

@macarlotal

Inmaculada Fernández photo

@inmafernandezv

Javier Ampuero photo

@Dr_Ampuero

Clinical trial design for MetALD 🤔 @juanpabloarab shows us how we will need to account for common mechanistic pathways 🍻🍔 More questions than answers, great opportunities for research 👩‍🔬 #TLM2024 @AASLDtweets

Tweet Image 1

David Marti Aguado Reposted

ALD and MASLD are a lot alike. How do we tell them apart on pathology? Cindy Behling walks us through in this fantastic talk. 👏 #TLM24 #LiverTwitter @AASLDtweets @juanpabloarab #pathologytwitter

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

David Marti Aguado Reposted

⁦Dr. @norahterrault⁩ shows a powerful slide on epidemiological differences between MASLD, MetALD, ALD: 🍺➡️highest MALO and liver-related ☠️ MASLD + 🍺🟰MetALD MASLD / MetALD ➡️similar ❤️ ☠️ ⁦@AASLDtweets⁩ ⁦@juanpabloarab⁩ ⁦@AlinaAllenMD#TLM2024

Tweet Image 1

Interacticon between alcohol and metabolic dysfunction is the 🔥 topic in #TLM2024 @AASLDtweets Now 🔝 @LuisAntonioDiaz magically talking about SLD natural history and drivers of fibrosis. @juanpabloarab @rabataller

Tweet Image 1
Tweet Image 2

David Marti Aguado Reposted

Isolated elevated alkaline phosphatase? Tired: GGT Wired: Fractionated alkaline phosphatase And what are the causes? A new study

Tweet Image 1

David Marti Aguado Reposted

Soy valenciano y me ha costado mucho hacer esto. Quiero visibilizar esta tragedia, que sirva de algo. Imágenes del 29/10/2024 al 01/11/2024.


David Marti Aguado Reposted

A work up for liver disease is not “full” without a PETH


David Marti Aguado Reposted

AASLD is pleased to announce our latest update for our 2023 Practice Guidance on the Clinical Assessment and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). View the latest update online now! journals.lww.com/hep/fulltext/9… #AASLD #AASLDNews #MASLD #MASH


David Marti Aguado Reposted

La @CGCOM_Esp y la @sepdigestiva tienen el placer de invitarle a la presentación del: 📖 Libro Blanco sobre el Cribado Poblacional de Cáncer Colorrectal en España Con la intervención de: 🗣️@Monica_Garcia_G Ministra @sanidadgob 🗣️@TomasCoboCastro Presidente #OMC.…

Tweet Image 1

David Marti Aguado Reposted

Necesidades no cubiertas en pacientes con hepatitis autoinmune (y son unas cuantas): 👉 Solo el 62% de los pacientes logran respuesta completa tras 1 año de tto ⚠️ Apenas el 27% lo consigue sin esteroides 🔄 30% de los pacientes cambian de tratamiento por intolerancia o no…

Tweet Image 1
Tweet Image 2

David Marti Aguado Reposted

Screening Strategies for High-Risk MASLD in Primary Care are cost-effective.👍💰👍 Pharmaco-economic study:👉onlinelibrary.wiley.com/doi/10.1111/li… @Echosens @semfyc @SEMERGEN_CV @redGDPS @NovoNordiskES @EASLnews

Tweet Image 1

David Marti Aguado Reposted

🟠 Yo #AVecesVeoHígados... ¿y tú? 📸¡Atención #liverlovers! Ponemos en marcha un #concurso de #fotos con motivo de nuestro 50º #CongresoAEEH! 📌Participa en #AVecesVeoHígados, publicando tu foto en redes y etiquétanos (@AEEHLiver). ¡Hay que ser original y no usar la #IA!…


David Marti Aguado Reposted

Screening effectiveness much more than test accuracy This 🇫🇷study: 0.26% of the total screened population diagnosed w. cirrhosis. nature.com/articles/s4159… The leaky referral pathway? Of n=135 with FIB4≥2.67 👉88 wrongful FIB-4 meas. 👉7 lost to FU before VCTE 👉7 lost after VCTE

Tweet Image 1

David Marti Aguado Reposted

Hepatocellular carcinoma: diagnosis in high risk patients. - Contrast enhanced CT or MRI as 1st line - >10mm, non-rim arterial phase hyperenhancement (APHE), non-peripheral washout, enhancing capsule & growth - LI-RADS score to categorise probability of HCC

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

David Marti Aguado Reposted

🟠¡Recuerda! 📅Hasta el 5 de noviembre está abierto el plazo de envío de comunicaciones para nuestro próximo #CongresoAEEH! Puedes hacerlo aquí👇 abstractsoasis.com/Congreso/35-50… En 2025 estaremos de celebración porque cumpliremos 50 años. Por eso ya estamos organizando algo especial y…

Tweet Image 1

David Marti Aguado Reposted

Alcohol plus metabolic syndrome 1 + 1 = 3 #imtld2024

Tweet Image 1

David Marti Aguado Reposted

Prevention of cirrhosis decompensation is the priority Transplant only helps a fortunate few Early diagnosis and improved etiologic and supportive care needed Gines at #IMTLD2024

Tweet Image 1

David Marti Aguado Reposted

📢¡Atent@s! Ya está abierto el plazo de envío de resúmenes para el 50 #Congreso Anual de la #AEEH que celebraremos en Madrid del 25 al 28 de febrero 2025. ⏳La fecha tope de envío será el 5 de noviembre. 💻Accede a la plataforma de resúmenes pinchando sobre la imagen o aquí. Te…

Tweet Image 1

David Marti Aguado Reposted

🚨🚨 Big news! We’ve identified 4️⃣ new clusters in acute-on-chronic liver failure (#ACLF) using machine learning 🤖! Each cluster has unique survival and treatment pathways. This could be first step to personalise care in #ACLF patients 🏥🩺. #AI onlinelibrary.wiley.com/doi/10.1111/ap…


David Marti Aguado Reposted

Register on-line for the "XV INTERNATIONAL MEETING on THERAPY in LIVER DISEASES". Live subtitles into English/Spanish/Portuguese & Chinese. Register in interactive sessions: 🔸Practical Clinical Workshops at the Liver Unit. 🔸Meet-the-Expert meetings.

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.